Region: Global
Category: Diagnostics

Global Diagnostics

(7,608 reports matching your criteria)
  • In-Vitro Colorectal Cancer Screening Tests

    ... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More

  • Heavy Metal Testing

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.1 Billion by ... Read More

  • Human Papillomavirus (HPV) Testing

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More

  • X-Ray Photoelectron Spectroscopy

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by ... Read More

  • Helicobacter Pylori Diagnostics

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More

  • Clinical Risk Grouping Solutions

    ... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More

  • Multiplex Assays

    ... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More

  • Mycotoxin Testing

    ... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More

  • Nuclear Medicine Radioisotope

    ... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by ... Read More

  • Paper Diagnostics

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the ... Read More

  • Herpes Marker Testing

    ... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More

  • Nucleic Acid Labeling

    ... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More

  • The Global Microfluidics Market 2025-2035

    ... to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process ... Read More

  • Refurbished Medical Imaging Equipment

    ... 2030, growing at a CAGR of 10.6% over the analysis period 2023-2030. CT Scanners, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.9 Billion by the ... Read More

  • Veterinary Hematology Analyzers

    ... at a CAGR of 5.3% over the analysis period 2023-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end ... Read More

  • Rapid Medical Diagnostic Kits

    ... 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$10.7 ... Read More

  • Cell Analysis

    ... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More

  • Hyperspectral Imaging Systems

    ... by 2030, growing at a CAGR of 18.6% over the analysis period 2023-2030. Cameras, one of the segments analyzed in the report, is expected to record a 19.5% CAGR and reach US$53.0 Billion by the ... Read More

  • MRI Systems

    ... at a CAGR of 5.8% over the analysis period 2023-2030. Closed MRI Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.6 Billion by the end ... Read More

  • Nucleic Acid Isolation and Purification

    ... is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected ... Read More

  • Coagulation Testing

    ... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More

  • Histology and Cytology

    ... by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$50.6 Billion by the ... Read More

  • Oncology Molecular Diagnostics

    ... by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by ... Read More

  • Antithrombin

    ... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More

  • Thyroid Function Tests

    ... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings